Treace Medical Concepts, Inc. (TMCI)
NASDAQ · Healthcare
Treace Medical Concepts, Inc. EBITDA 2019–2025
Treace Medical Concepts, Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Treace Medical Concepts, Inc. ebitda for the quarter ending March 31, 2026 was -16.3 M, a 23.98% increase year-over-year.
- Treace Medical Concepts, Inc. ebitda for the twelve months ending March 31, 2026 was -58.4 M, a 35.61% increase year-over-year.
- Treace Medical Concepts, Inc. annual ebitda for 2025 was -43.5 M, a 7.91% decrease from 2024.
- Treace Medical Concepts, Inc. annual ebitda for 2024 was -47.3 M, a 2.59% increase from 2023.
- Treace Medical Concepts, Inc. annual ebitda for 2023 was -46.1 M, a 40.86% increase from 2022.
- Treace Medical Concepts, Inc. annual ebitda for 2022 was -32.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Treace Medical Concepts, Inc. EBITDA — FAQ
Treace Medical Concepts, Inc. (TMCI) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TMCI's ebitda history?
The chart and table above show Treace Medical Concepts, Inc.'s ebitda by year and by quarter, including the growth rate.